🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
India's Lupin to sell generic respiratory drugs on Mark Cuban's online pharmacy
Reuters
·
1y ago
Medial
Lupin, an Indian pharmaceutical company, will sell its generic drugs for treating certain respiratory disorders through Mark Cuban's online pharmacy, Cost Plus Drugs, in the United States. This partnership aims to strengthen Lupin's U.S. business, which already contributes significantly to its revenue. Lupin's generic drug, tiotropium bromide inhalation powder, is primarily used to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), a condition that affects over 15 million adults in the United States. Cost Plus Drugs focuses on offering drugs at lower prices by sourcing directly from manufacturers.
View Source
Related News
Lightbox-backed Zeno Health buys online pharmacy startup
VCCircle
·
1y ago
Medial
Zeno Health, a healthcare company backed by Lightbox, has acquired online pharmacy startup Tablt Pharmacy in an all-stock deal. The financial details of the deal were not disclosed. The acquisition will help Zeno Health expand its presence in West Bengal, Odisha, Bihar, and Jharkhand, where Tablt operates. Zeno Health operates 180 omnichannel stores and a network of 200 micro-franchises, offering generic and branded prescription medicines. Tablt Pharmacy, founded in 2018, focuses on serving smaller towns in the eastern region of India and has approximately 300 franchises.
View Source
Pharmacy startup Zeno Health raises $25 million in funding round led by STIC Investments
Economic Times
·
1y ago
Medial
Zeno Health, a pharmacy chain focused on generic medicine, has raised $25 million in a Series C funding round led by STIC Investments. Existing investor Lightbox Ventures also participated. The Mumbai-based company, formerly known as Generico, primarily sells generic medicines and operates a franchise pharmacy network called Zeno Health. The funding will be used to expand the company's consumer base and footprint, as well as enhance its technological infrastructure. Zeno Health currently operates 180 stores and serves 2.5 million consumers.
View Source
Zeno Health Bags $25 Mn Funding To Bolster Its Omnichannel Pharmacy Play
Inc42
·
1y ago
Medial
Mumbai-based healthtech startup Zeno Health has raised $25 million in a Series C funding round led by South Korean private equity firm STIC Investments. The funds will be used to fuel the company's growth, expand its operations, and enhance its technological infrastructure. Zeno Health, founded in 2017 by Siddharth Gadia and Girish Agarwal, operates an omnichannel pharmacy platform that sells generic medicines. The company aims to make quality healthcare affordable and has plans to reach 10 million consumers monthly. The online pharmacy market in India is projected to reach INR 8,947 crore by 2027.
View Source
Lupin launches Mirabegron extended-release tablets in US after USFDA nod
Money Control
·
11m ago
Medial
Pharmaceutical company Lupin has launched its generic version of Mirabegron extended-release tablets for the treatment of overactive bladder. The US Food and Drug Administration granted approval for the product, which is equivalent to Myrbetriq from Astellas Pharma Global Development. Myrbetriq has estimated annual sales of $1.6 billion in the US. This follows Lupin's recent launch of a generic cancer treatment drug in the US market.
View Source
Online pharmacies could face stricter check-ups
Economic Times
·
1m ago
Medial
The Indian government is planning to tighten regulations on online pharmacy platforms due to increasing complaints about unverified prescriptions and a surge in such platforms. E-pharmacies currently lack specific regulations under the Drugs and Cosmetics Act. This move is part of a broader effort to scrutinize the industry and address concerns posed by these platforms' rapid expansion. Meanwhile, the All-India Organisation of Chemists and Druggists demands a repeal of pandemic-era rules allowing doorstep delivery of medicines.
View Source
Online video games, the latest hunting grounds for drug cartels
Economic Times
·
1y ago
Medial
Drug cartels are turning to online video games like "Grand Theft Auto" and "World of Warcraft" to discreetly sell drugs and recruit dealers. The dark web is becoming less popular among cartels due to increased law enforcement surveillance, while online games provide an unmonitored space for communication. Symbols and emojis are used by traffickers to avoid detection, with specific symbols representing drugs or activities. The Council of Europe's Pompidou Group has held a forum to raise awareness about this issue and suggests better education for parents and children regarding the risks of online gaming.
View Source
Trump Inks Order to Bring Down US Drug Prices, But Skips Details on Generics Drugs
OutlookIndia
·
2m ago
Medial
President Donald Trump signed an executive order to significantly reduce US prescription drug prices by over 59%, aiming to align them with prices in other developed nations. The plan revives the 'Most Favoured Nation' pricing model but lacks details on its effect on generic drugs, leaving Indian pharma companies concerned about its implications. While specifics on medication coverage weren't provided, analysts believe branded and specialty drugs will be most affected, potentially impacting companies like Sun Pharma.
View Source
Best pharma stocks to buy today as recommended by expert Raja Venkatraman
Livemint
·
1m ago
Medial
Market expert Raja Venkatraman recommends three pharma stocks to watch on 16 June, noting significant growth and innovation within the Indian pharmaceutical sector. The sector is experiencing a shift from generic drugs to more innovative products and global expansion, with recent robust performance and a promising outlook.
View Source
Go on, pop the innovation pill: ₹5,000 cr push signals India’s shift from copy to create - The Economic Times
Economic Times
·
1m ago
Medial
India's pharmaceutical sector is transitioning from a generic-focused industry to innovation-led growth, driven by the ₹5,000-crore PRIP scheme supporting research and development. As lucrative drug patents approach expiration, Indian companies have opportunities to tap into affordable drug production. Multi-national corporations are partnering with Indian firms, enhancing market presence. Challenges include regulatory compliance and quality infrastructure. The industry's growth is further supported by government initiatives, including customs duty exemptions on life-saving drugs and expansion of healthcare infrastructure.
View Source
Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal
VCCircle
·
1y ago
Medial
Kelix Bio, a specialty generic biopharmaceutical company, plans to acquire five pharmaceutical entities based in the UAE. The move comes after the company's acquisition by Mubadala Investment Company, Abu Dhabi's sovereign investor. Kelix Bio aims to expand its product portfolio of affordable critical drugs and boost growth in emerging markets.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in
/cloudfront-us-east-2.images.arcpublishing.com/reuters/O45WQ456ZVJEXF4DMT62QQUHQQ.jpg)
